These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2891535)

  • 1. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients.
    Holford NH; Clements P; Collier P; Orie NG; van Bork LE; Jonkman JH
    Eur J Clin Pharmacol; 1987; 33(3):237-42. PubMed ID: 2891535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intramuscular administration of thiazinamium and inhaled histamine on forced inspiratory volume in 1 s.
    Gimeno F; van Altena R
    Respiration; 1993; 60(4):227-31. PubMed ID: 7903469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfate.
    Jonkman JH; Van Bork LE; Calvert B; Greving JE; Wijsbeek J; De Zeeuw RA; Orie NG
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):454-9. PubMed ID: 6138313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
    Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration.
    Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in the bioavailability of thiazinamium methylsulfate.
    Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
    Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis.
    Verheijen-Breemhaar L; Bogaard JM; Hilvering C
    Pharmatherapeutica; 1982; 3(3):180-7. PubMed ID: 6127719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of promethazine after intravenous administration in camels.
    Wasfi IA; Barezaiq IM; Alkatheeri N; Hadi AA; Boni NS; Almuhrami AM; Elghazali M
    Res Vet Sci; 1999 Apr; 66(2):159-60. PubMed ID: 10208894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilating drugs and airway reactivity.
    Guerrin F; Robin H; Lahoutte C; Voisin C
    Eur J Respir Dis Suppl; 1980; 106():71-5. PubMed ID: 6110561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative bronchodilator properties of alkyl quaternary salts of promethazine.
    Lewis AJ; Dervinis A; Rosenthale ME; Santilli AA; Buzby GC
    Int Arch Allergy Appl Immunol; 1984; 75(3):282-3. PubMed ID: 6148311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and therapeutic use of thiazinamium (Multergan)].
    van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K
    Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG
    Pharm Weekbl Sci; 1982 Oct; 4(5):129-34. PubMed ID: 6128714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels and bronchodilatation after intravenous administration of theophylline in asthmatic patients].
    Andrejak M; Lary H; Aubry P; Levi-Valensi P
    Rev Pneumol Clin; 1986; 42(2):82-6. PubMed ID: 3749701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous injection of rimiterol in asthma.
    Tarala RA; Martyn V; Paterson JW
    Br J Clin Pharmacol; 1981 Sep; 12(3):333-40. PubMed ID: 6117302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma.
    Blake K; Madabushi R; Derendorf H; Lima J
    Chest; 2008 Nov; 134(5):981-989. PubMed ID: 18583517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous injection of salbutamol in asthma.
    May CS; Paterson JW; Spiro SG; Johnson AJ
    Br J Clin Pharmacol; 1975 Dec; 2(6):495-501. PubMed ID: 1234013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of terbutaline in asthmatic patients.
    Ripe E; Hörnblad Y; Tegnér K
    Eur J Respir Dis Suppl; 1984; 134():171-9. PubMed ID: 6586478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD.
    Light RW; Stansbury DW; Webster JS
    Chest; 1996 Apr; 109(4):975-81. PubMed ID: 8635380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.